STOCK TITAN

HEALWELL AI INC A SUB VTG - HWAIF STOCK NEWS

Welcome to our dedicated page for HEALWELL AI A SUB VTG news (Ticker: HWAIF), a resource for investors and traders seeking the latest updates and insights on HEALWELL AI A SUB VTG stock.

HEALWELL AI Inc. (HWAIF) is a healthcare technology company specializing in AI and data science for preventative care. Recently, the company participated in groundbreaking research on Chronic Kidney Disease (CKD) published in the American Journal of Kidney Diseases. HEALWELL's AI-powered clinical decision support technology aids Nephrologists in improving guideline-recommended testing for CKD patients. The company's second-generation AI Clinical Co-Pilot continues to enhance patient care. With the recent acquisition of BioPharma Services Inc., a top Contract Research Organization, HEALWELL expands its clinical research offerings, focusing on advancing patient-centered clinical trials and leveraging AI-driven recommendations to accelerate recruitment. HEALWELL aims to revolutionize preventative care and improve patient health outcomes through cutting-edge technology and strategic partnerships.

Rhea-AI Summary
Hamed Shahbazi appointed Chairman of HEALWELL AI, a global leader in AI-powered preventative care, with strategic importance for WELL Health Technologies and HEALWELL shareholders. WELL holds a significant ownership stake in HEALWELL and has an option for a controlling position. The shared objective is to develop advanced AI tools for healthcare providers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.36%
Tags
AI
-
Rhea-AI Summary
Healwell's Healthcare AI garners attention for its innovative technology and market potential, backed by expert endorsements and strong leadership.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.58%
Tags
-
Rhea-AI Summary
HEALWELL AI Inc. announces successful implementation of Intrahealth's Profile EHR at Canuck Place Children's Hospice, showcasing growth opportunities and potential revenue increase. The acquisition of Intrahealth proves beneficial with active pipeline and AI integration plans, aiming to enhance healthcare outcomes and reduce costs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.03%
Tags
AI
Rhea-AI Summary
Pentavere continues to publish groundbreaking AI work accepted at global medical conferences, in partnership with leading academic centers and pharmaceutical companies. The OECD referenced their AI work, stating that AI can help health professionals provide more time to care and improve outcomes. Pentavere's AI engine, DARWEN™, enables effortless data access and rapid insight generation. The CEO of HEALWELL AI Inc. emphasized the power of AI to drive significant improvements in preventative care and patient outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.74%
Tags
AI
-
Rhea-AI Summary
HEALWELL has completed the acquisition of Intrahealth, a SaaS based EHR provider with a global network of clinicians. Intrahealth is expected to generate over $12 million in revenues in 2024 with double digit organic growth. HEALWELL plans to integrate AI tools with Intrahealth to create a next generation AI Powered EHR platform for better healthcare outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.61%
Tags
-
Rhea-AI Summary
HEALWELL AI Inc. has entered into an agreement to acquire Intrahealth Systems Limited, a subsidiary of WELL Health Technologies Corp. Intrahealth is a SaaS-based Electronic Health Records management platform for small and medium enterprise healthcare organizations across Canada, Australia, and New Zealand. The acquisition is valued at approximately $24.2 million, with the majority expected to be paid in HEALWELL Class A subordinate voting shares. Intrahealth is expected to generate over $12 million in revenues in 2024, reflecting double-digit organic growth, and historically achieving over 80% gross margins, positive EBITDA, and positive cashflows. HEALWELL plans to integrate its AI tools with Intrahealth to create a next-generation AI-powered EHR to amplify healthcare providers and drive better health outcomes at lower costs in line with global Value Based Care trends.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.51%
Tags
Rhea-AI Summary
HEALWELL AI Inc. has recently raised $29.5 million and acquired Pentavere Research Group and a minority investment in a German EMR company. The company aims to acquire, invest in, and partner with data-focused companies to integrate its AI technologies for next-generation clinical decision support capabilities. The AI technologies are expected to support Value Based Care trends and drive better health outcomes at lower costs. The company is also re-engaging its Clinical Decision Support commercial roadmap, launching a Real-World Evidence product, and expanding its pipeline of existing pharma relationships.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI
-
Rhea-AI Summary
HEALWELL AI Inc. (AIDX) to participate in multiple investor conferences, including the 42nd Annual J.P. Morgan Healthcare Conference and the Maxim Group 2024 Healthcare IT Virtual Conference, showcasing its focus on preventative care and AI technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences AI
-
Rhea-AI Summary
HEALWELL AI Inc. (AIDX) completes acquisition of a majority stake of Pentavere Research Group Inc., an innovative AI health-tech company. The acquisition adds revenue, new pharmaceutical and life sciences customers, access to hospitals, and a growing team of AI engineers. The transaction is expected to be financially and strategically accretive and highly synergistic with HEALWELL’s strategic alliance agreement with WELL Health Technologies Corp. ('WELL') (TSX: WELL).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.54%
Tags
Rhea-AI Summary
HEALWELL AI Inc. (AIDX) to Begin Trading on OTCQX as HWAIF, DTC Eligibility Expected to Increase Accessibility for U.S. Investors
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI

FAQ

What is the current stock price of HEALWELL AI A SUB VTG (HWAIF)?

The current stock price of HEALWELL AI A SUB VTG (HWAIF) is $1.033 as of September 13, 2024.

What is the market cap of HEALWELL AI A SUB VTG (HWAIF)?

The market cap of HEALWELL AI A SUB VTG (HWAIF) is approximately 228.1M.

What is HEALWELL AI Inc.?

HEALWELL AI Inc. is a healthcare technology company focused on AI and data science for preventative care.

What recent research has HEALWELL AI Inc. participated in?

HEALWELL AI Inc. recently participated in research on Chronic Kidney Disease (CKD) published in the American Journal of Kidney Diseases.

What is the focus of HEALWELL's AI-powered technology?

HEALWELL's AI-powered technology aids Nephrologists in improving guideline-recommended testing for CKD patients and enhances patient care.

What recent acquisition has HEALWELL made?

HEALWELL recently acquired BioPharma Services Inc., a leading Contract Research Organization specializing in early clinical trials.

What is HEALWELL's goal with the acquisition of BioPharma Services Inc.?

HEALWELL aims to expand its clinical research capabilities, focusing on patient-centered clinical trials and leveraging AI-driven recommendations to accelerate recruitment.

How does HEALWELL plan to revolutionize healthcare?

HEALWELL aims to revolutionize preventative care and improve patient health outcomes through cutting-edge technology and strategic partnerships.

What sectors does HEALWELL specialize in?

HEALWELL specializes in AI and data science for healthcare, with a focus on preventative care and clinical research.

What is the significance of HEALWELL's research on Chronic Kidney Disease?

HEALWELL's research on Chronic Kidney Disease published in the American Journal of Kidney Diseases highlights the impact of advanced technology in supporting improved patient care for chronic diseases.

How does HEALWELL plan to utilize AI technology in healthcare?

HEALWELL plans to leverage AI technology to improve patient care, accelerate recruitment for clinical trials, and enhance healthcare outcomes.

What partnerships has HEALWELL established for research and development?

HEALWELL has partnered with reputable organizations like BioPharma Services Inc. for expanding its clinical research capabilities and advancing patient-centered care.

What benefits can patients and healthcare providers expect from HEALWELL's technology?

Patients and healthcare providers can expect improved care, accelerated recruitment for clinical trials, and enhanced healthcare outcomes through HEALWELL's cutting-edge technology and AI-driven solutions.

HEALWELL AI INC A SUB VTG

OTC:HWAIF

HWAIF Rankings

HWAIF Stock Data

228.08M
125.91M
36.48%
Medical Care Facilities
Healthcare
Link
United States of America
Toronto